ABT Wutah bathi resik saben saham ing taun iki Abbott Corp.

Simbol resmi perusahaan Abbott Corp. (ABT)

High FDA certification costs and patent protection create significant barriers to entry for Abbott Laboratories (ABT). The 12-month EPS growth rate demonstrates profitability dynamics amid these constraints, where 7.30 characterizes this valuation parameter. Efficient transportation of fragile instruments supports supply stability, while rising demand for home diagnostics expands sales markets.

Wutah bathi ing taun lumaku: Abbott Corp. (ABT) kanggo 04.07.2022 - 12.11.2026

Rincian metrik keuangan lan pasar Abbott Laboratories (ABT)

- rega saham lan target rega konsensus:
Bagan owah-owahan rega Abbott Labs|ABT - Bagan rega target
- data kapitalisasi pasar:
Biji pasar Abbott Corp.|ABT - Nilai Perusahaan
- rincian nilai buku perusahaan:
Nilai Aset Bersih saben Saham Abbott|ABT - Kapitalisasi Buku|Rasio Kapitalisasi marang Nilai Buku abbott.com|ABT - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Koefisien Total Utang marang Modal Abbott Laboratories|ABT - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas abbott.com|ABT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Abbott Corp.|ABT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Abbott|Rasio jangkoan perantara abbott.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ABT - Bathi resik|Bathi resik sing dikarepake Abbott Laboratories|ABT - Rasio rega marang bathi|Pangali forward rega marang bathi Abbott Corp.|ABT - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Abbott Corp.|ABT - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Abbott|ABT - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan abbott.com|ABT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Abbott Laboratories
Pambiji fundamental:Abbott Laboratories
Produk seri Abbott

Abbott Laboratories' impeccable reputation in diagnostics ensures a steady inflow of capital, which is reflected in the year-over-year earnings per share dynamics. By analyzing the annual EPS progress, an investor assesses the percentage change in net income, where a sharp spike may signal an overvalued asset, while a steady ascent confirms the business's resilience to external shocks.

Pesaing utama

Thermo Fisher Scientific Inc. - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku GE Healthcare Corp|Wutah bathi resik saben saham ing taun iki Mettler Toledo Inc (MTD)|Wutah bathi ing taun lumaku WAT|TECH - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku BRKR (Bruker)|AZTA: Wutah bathi saben saham ing taun iki|Varex - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Semler SMLR|BFLY: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki mesalabs.com|QSI (Quantum-Si Incorporated) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Nano-X Imaging|Wutah bathi saben saham ing taun lumaku Quanterix Corp (QTRX)|Wutah bathi saben saham ing taun lumaku MASS (908 Devices Corporation)|CapsoVision - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku MXCT|Rapid Micro - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Seer Inc|Hyperfine Corp (HYPR) - Wutah bathi saben saham ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku FONAR Corporation Inc FONR|Wutah bathi resik saben saham ing taun iki DXR|Wutah bathi ing taun lumaku spectral-ai.com|Wutah bathi ing taun lumaku VIVS|Prakiraan wutah bathi resik saben saham ing taun iki Aclarion Inc|Wutah bathi saben saham ing taun lumaku Akoya Biosciences, Inc. AKYA|THMO (Cesca Therapeutics) - Dinamika bathi saben saham ing taun lumaku|TLIS - Wutah bathi saben saham ing taun lumaku|t2biosystems.com (TTOO) - Wutah bathi resik saben saham ing taun iki